10 20 30 40 50 60 70 80 2AAX - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSCRIPTION 14-JUL-05 2AAX
TITLE MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND TITLE 2 CORTISONE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: MR; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS GST
KEYWDS MINERALOCORTICOID RECEPTOR, MR, NUCLEAR RECEPTOR, STEROID KEYWDS 2 RECEPTOR, CORTISONE, HYPERTENSION, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO,M.H.LAMBERT, AUTHOR 2 K.H.PEARCE,T.B.STANLEY,E.L.STEWART,R.P.TRUMP,T.M.WILLSON, AUTHOR 3 S.P.WILLIAMS
REVDAT 3 24-FEB-09 2AAX 1 VERSN REVDAT 2 13-SEP-05 2AAX 1 JRNL REVDAT 1 26-JUL-05 2AAX 0
JRNL AUTH R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO, JRNL AUTH 2 M.H.LAMBERT,K.H.PEARCE,T.B.STANLEY,E.L.STEWART, JRNL AUTH 3 R.P.TRUMP,T.M.WILLSON,S.P.WILLIAMS JRNL TITL A LIGAND-MEDIATED HYDROGEN BOND NETWORK REQUIRED JRNL TITL 2 FOR THE ACTIVATION OF THE MINERALOCORTICOID JRNL TITL 3 RECEPTOR JRNL REF J.BIOL.CHEM. V. 280 31283 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15967794 JRNL DOI 10.1074/JBC.M504098200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 67454 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4780 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4549 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 305 REMARK 3 BIN FREE R VALUE : 0.3260 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4131 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 443 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.53000 REMARK 3 B22 (A**2) : 0.85000 REMARK 3 B33 (A**2) : -0.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.108 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.940 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4296 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5852 ; 1.459 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 3.956 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 668 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3206 ; 0.016 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2002 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 300 ; 0.174 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 71 ; 0.231 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.230 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2600 ; 0.986 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4201 ; 1.861 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1696 ; 3.031 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1651 ; 5.074 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2AAX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUL-05. REMARK 100 THE RCSB ID CODE IS RCSB033694.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67532 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 16.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.40700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: MR LBD REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH7.5, 0.9M LI2SO4, 2% REMARK 280 PEG 2KMME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.16000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.26850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.06250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.26850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.16000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.06250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC REMARK 300 ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL REMARK 300 UNIT IS A DIMER, BUT THE DIMER IN THE CRYSTAL IS IRRELEVANT REMARK 300 BIOLOGICALLY. THE BIOLOGICAL DIMER IS CURRENTLY UNKNOWN.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 710 REMARK 465 SER A 711 REMARK 465 ALA A 712 REMARK 465 PRO A 713 REMARK 465 ALA A 714 REMARK 465 LYS A 715 REMARK 465 GLU A 716 REMARK 465 PRO A 717 REMARK 465 SER A 718 REMARK 465 VAL A 719 REMARK 465 ASN A 720 REMARK 465 THR A 721 REMARK 465 PRO A 911 REMARK 465 LYS A 984 REMARK 465 GLY B 710 REMARK 465 SER B 711 REMARK 465 ALA B 712 REMARK 465 PRO B 713 REMARK 465 ALA B 714 REMARK 465 LYS B 715 REMARK 465 GLU B 716 REMARK 465 PRO B 717 REMARK 465 SER B 718 REMARK 465 VAL B 719 REMARK 465 ASN B 720 REMARK 465 THR B 721 REMARK 465 ALA B 722 REMARK 465 LYS B 909 REMARK 465 CYS B 910 REMARK 465 PRO B 911 REMARK 465 ARG B 983 REMARK 465 LYS B 984
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 727 CG CD1 CD2 REMARK 470 ARG A 732 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 763 CG CD OE1 OE2 REMARK 470 ARG A 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 791 CG CD CE NZ REMARK 470 GLU A 796 CG CD OE1 OE2 REMARK 470 LYS A 820 CG CD CE NZ REMARK 470 ARG A 861 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 883 CG CD CE NZ REMARK 470 LYS A 905 CG CD CE NZ REMARK 470 LYS A 909 CG CD CE NZ REMARK 470 CYS A 910 SG REMARK 470 ASN A 912 CG OD1 ND2 REMARK 470 GLN A 916 CG CD OE1 NE2 REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 ARG A 983 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 727 CG CD1 CD2 REMARK 470 ARG B 732 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 748 CG CD OE1 OE2 REMARK 470 GLU B 763 CG CD OE1 OE2 REMARK 470 ARG B 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 791 CG CD CE NZ REMARK 470 GLU B 796 CG CD OE1 OE2 REMARK 470 LYS B 883 CG CD CE NZ REMARK 470 LYS B 901 CG CD CE NZ REMARK 470 ARG B 904 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 916 CG CD OE1 NE2 REMARK 470 LYS B 926 CG CD CE NZ
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 779 O HOH A 368 2.10 REMARK 500 O HOH B 239 O HOH B 369 2.12 REMARK 500 O HOH B 110 O HOH B 440 2.13 REMARK 500 O HOH A 362 O HOH A 363 2.15 REMARK 500 O HOH B 169 O HOH B 170 2.16 REMARK 500 OD1 ASP A 966 O HOH A 442 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 364 O HOH B 447 4555 2.11 REMARK 500 O HOH A 204 O HOH A 442 1455 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 884 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 929 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 929 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 833 85.27 -154.79 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 288 DISTANCE = 5.85 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PDN A 502 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PDN B 503
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AA2 RELATED DB: PDB REMARK 900 MR WITH BOUND ALDOSTERONE REMARK 900 RELATED ID: 2AA5 RELATED DB: PDB REMARK 900 MR WITH BOUND PROGESTERONE REMARK 900 RELATED ID: 2AA6 RELATED DB: PDB REMARK 900 MR DOUBLE MUTANT WITH BOUND PROGESTERONE REMARK 900 RELATED ID: 2AA7 RELATED DB: PDB REMARK 900 MR WITH BOUND DEOXYCORTICOSTERONE REMARK 900 RELATED ID: 2AB2 RELATED DB: PDB
DBREF 2AAX A 712 984 UNP P08235 MCR_HUMAN 712 984 DBREF 2AAX B 712 984 UNP P08235 MCR_HUMAN 712 984
SEQADV 2AAX GLY A 710 UNP P08235 CLONING ARTIFACT SEQADV 2AAX SER A 711 UNP P08235 CLONING ARTIFACT SEQADV 2AAX SER A 808 UNP P08235 CYS 808 ENGINEERED SEQADV 2AAX LEU A 810 UNP P08235 SER 810 ENGINEERED SEQADV 2AAX GLY B 710 UNP P08235 CLONING ARTIFACT SEQADV 2AAX SER B 711 UNP P08235 CLONING ARTIFACT SEQADV 2AAX SER B 808 UNP P08235 CYS 808 ENGINEERED SEQADV 2AAX LEU B 810 UNP P08235 SER 810 ENGINEERED
SEQRES 1 A 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 A 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 A 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 A 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 A 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 A 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 A 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 A 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 A 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 A 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 A 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 A 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 A 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 A 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 A 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 A 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 A 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 A 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 A 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 A 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 A 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 A 275 ARG LYS SEQRES 1 B 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 B 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 B 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 B 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 B 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 B 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 B 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 B 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 B 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 B 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 B 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 B 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 B 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 B 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 B 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 B 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 B 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 B 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 B 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 B 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 B 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 B 275 ARG LYS
HET SO4 A 501 5 HET PDN A 502 26 HET PDN B 503 26
HETNAM SO4 SULFATE ION HETNAM PDN 17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE
HETSYN PDN PREDNISONE; 1,4 PREGNADIENE-17ALPHA,21-DIOL-3,11,20- HETSYN 2 PDN TRIONE; 1-CORTISONE; DEHYDROCORTISONE
FORMUL 3 SO4 O4 S 2- FORMUL 4 PDN 2(C21 H26 O5) FORMUL 6 HOH *443(H2 O)
HELIX 1 1 SER A 728 THR A 735 1 8 HELIX 2 2 SER A 737 GLU A 746 1 10 HELIX 3 3 THR A 761 VAL A 786 1 26 HELIX 4 4 GLY A 789 LEU A 793 5 5 HELIX 5 5 PRO A 794 ASN A 823 1 30 HELIX 6 6 ASN A 836 SER A 843 1 8 HELIX 7 7 MET A 845 GLN A 863 1 19 HELIX 8 8 THR A 865 LEU A 878 1 14 HELIX 9 9 SER A 888 VAL A 907 1 20 HELIX 10 10 ASN A 913 GLU A 948 1 36 HELIX 11 11 GLU A 948 LYS A 953 1 6 HELIX 12 12 PRO A 957 SER A 973 1 17 HELIX 13 13 SER B 728 THR B 735 1 8 HELIX 14 14 SER B 737 GLU B 746 1 10 HELIX 15 15 THR B 761 VAL B 786 1 26 HELIX 16 16 GLY B 789 LEU B 793 5 5 HELIX 17 17 PRO B 794 ASN B 823 1 30 HELIX 18 18 ASN B 836 SER B 843 1 8 HELIX 19 19 MET B 845 GLN B 863 1 19 HELIX 20 20 THR B 865 LEU B 878 1 14 HELIX 21 21 SER B 888 VAL B 907 1 20 HELIX 22 22 ASN B 913 GLU B 948 1 36 HELIX 23 23 GLU B 948 LYS B 953 1 6 HELIX 24 24 PRO B 957 SER B 973 1 17
SHEET 1 A 2 LEU A 827 ALA A 830 0 SHEET 2 A 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 B 2 THR A 880 PRO A 882 0 SHEET 2 B 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SHEET 1 C 2 LEU B 827 ALA B 830 0 SHEET 2 C 2 LEU B 833 PHE B 835 -1 O PHE B 835 N LEU B 827 SHEET 1 D 2 THR B 880 PRO B 882 0 SHEET 2 D 2 ALA B 976 PRO B 978 -1 O LYS B 977 N ILE B 881
SITE 1 AC1 7 HOH A 105 HOH A 142 PRO A 759 ASP A 760 SITE 2 AC1 7 SER B 756 SER B 757 LYS B 953 SITE 1 AC2 13 LEU A 766 LEU A 769 ASN A 770 ALA A 773 SITE 2 AC2 13 GLN A 776 ARG A 817 PHE A 829 MET A 845 SITE 3 AC2 13 PHE A 941 CYS A 942 THR A 945 VAL A 954 SITE 4 AC2 13 PHE A 956 SITE 1 AC3 14 LEU B 766 LEU B 769 ASN B 770 ALA B 773 SITE 2 AC3 14 GLN B 776 LEU B 810 ARG B 817 PHE B 829 SITE 3 AC3 14 MET B 845 PHE B 941 CYS B 942 THR B 945 SITE 4 AC3 14 VAL B 954 PHE B 956
CRYST1 42.320 90.125 172.537 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023629 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011096 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005796 0.00000